Gould Gregory A Insider Trades

Insider Trading History

Track insider trading activity for Gould Gregory A. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Aclarion- Warrants (01/12/2026)
Aclarion- Warrants (01/12/2026) ACONW
CFO
Holding Value $500 17,000 shares
Last Trade
Sep 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$689 17,000 shares
$0.04
$0.03
Aclarion
Aclarion ACON
CFO
Holding Value $60k 17,000 shares
Last Trade
Sep 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$122k 17,000 shares
$7.15
$3.53
NewAge
NewAge NBEV
Chief Financial Officer
Holding Value $31k 331,255 shares
Last Trade
Jul 02, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$164k 73,110 shares
$2.24
$0.09
NewAge
NewAge NBEV
Chief Financial Officer
Holding Value $11.7k 125,000 shares
Last Trade
Mar 10, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$349k 125,000 shares
$2.79
$0.09
NewAge
NewAge NBEV
Chief Financial Officer
Holding Value $37.8k 404,365 shares
Last Trade
Jan 05, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$69.7k 26,507 shares
$2.63
$0.09
NewAge
NewAge NBEV
Chief Financial Officer
Holding Value $40.3k 430,872 shares
Last Trade
Dec 10, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$30.2k 9,564 shares
$3.16
$0.09
NewAge
NewAge NBEV
Chief Financial Officer
Holding Value $41.2k 440,436 shares
Last Trade
Oct 22, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$26k 9,564 shares
$2.72
$0.09
NewAge
NewAge NBEV
Chief Financial Officer
Holding Value $42.1k 450,000 shares
Last Trade
Dec 10, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$366k 200,000 shares
$1.83
$0.09
NewAge
NewAge NBEV
CFO
Holding Value $32.7k 350,000 shares
Last Trade
Jul 01, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.14M 450,000 shares
$4.75
$0.09
Aytu BioPharma
Aytu BioPharma AYTU
Chief Financial Officer
Holding Value $53.1k 25,000 shares
Last Trade
Mar 16, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.3k 45,834 shares
$0.29
$2.12
Aytu BioPharma
Aytu BioPharma AYTU
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Mar 16, 2017 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$7.25k 25,000 shares
$0.29
$2.12
Aytu BioPharma
Aytu BioPharma AYTU
Chief Financial Officer
Holding Value $723k 340,231 shares
Last Trade
Feb 27, 2017 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$19.3k 66,666 shares
$0.29
$2.12
Aytu BioPharma
Aytu BioPharma AYTU
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Feb 27, 2017 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$19.3k 66,666 shares
$0.29
$2.12
Aytu BioPharma
Aytu BioPharma AYTU
Chief Financial Officer
Holding Value $581k 273,565 shares
Last Trade
Nov 02, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$38.7k 133,332 shares
$0.29
$2.12
Aytu BioPharma
Aytu BioPharma AYTU
Chief Financial Officer
Holding Value $440k 206,899 shares
Last Trade
Aug 02, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.2k 41,899 shares
$0.29
$2.12
Ampio Pharmaceuticals
Ampio Pharmaceuticals AMPE
Chief Financial Officer
Holding Value $76.3k 416,666 shares
Last Trade
Jul 15, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.09M 150,000 shares
$20.60
$0.18
Aytu BioPharma
Aytu BioPharma AYTU
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Jul 07, 2016 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$6.04k 20,834 shares
$0.29
$2.12
Aytu BioPharma
Aytu BioPharma AYTU
Chief Financial Officer
Holding Value $351k 165,000 shares
Last Trade
Jul 07, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$61.1k 210,834 shares
$0.29
$2.12
Aytu BioPharma
Aytu BioPharma AYTU
Chief Financial Officer
Holding Value $531k 250,000 shares
Last Trade
Nov 11, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$72.5k 250,000 shares
$0.29
$2.12
Ampio Pharmaceuticals
Ampio Pharmaceuticals AMPE
Chief Financial Officer
Holding Value $18.3k 100,000 shares
Last Trade
Jul 30, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.42M 100,000 shares
$34.25
$0.18

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up